Cassava Sciences Files 8-K with Regulatory Updates
Ticker: FLNA · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financials, company-update
TL;DR
Cassava Sciences dropped an 8-K on Aug 4th - check it for regulatory and financial updates.
AI Summary
Cassava Sciences, Inc. filed an 8-K on August 4, 2025, reporting on various events. The filing includes information on Regulation FD disclosures, other events, and financial statements and exhibits. The company, formerly known as Pain Therapeutics Inc., is incorporated in Delaware and headquartered in Austin, Texas.
Why It Matters
This 8-K filing provides crucial updates on Cassava Sciences' regulatory and financial activities, which could impact investor understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant information, but without specific details on the nature of the disclosures, the risk level is moderate.
Key Numbers
- 001-41905 — SEC File Number (Identifies the company's filing with the SEC.)
- 91-1911336 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Cassava Sciences, Inc. (company) — Registrant
- Pain Therapeutics Inc. (company) — Former company name
- August 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Austin, Texas (location) — Principal Executive Offices
FAQ
What specific events are detailed under 'Regulation FD Disclosure'?
The filing indicates 'Regulation FD Disclosure' as an item, but the specific details of these disclosures are not provided in the excerpt.
What are the 'Other Events' reported in this 8-K?
The filing lists 'Other Events' as a category, but the nature of these events is not specified in the provided text.
What is the significance of the 'Financial Statements and Exhibits' section?
This section indicates that financial statements and supporting exhibits are part of the filing, which are crucial for understanding the company's financial health.
When did Cassava Sciences change its name from Pain Therapeutics Inc.?
The date of the name change from Pain Therapeutics Inc. to Cassava Sciences, Inc. was March 9, 2000.
What is the principal executive office address for Cassava Sciences?
The principal executive offices are located at 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas 78731.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding CASSAVA SCIENCES INC (FLNA).